Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 1 |
NetGPI | no | yes: 0, no: 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0016020 | membrane | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HCA2
Term | Name | Level | Count |
---|---|---|---|
GO:0051179 | localization | 1 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.449 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.624 |
CLV_PCSK_PC1ET2_1 | 87 | 89 | PF00082 | 0.624 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.549 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.609 |
DOC_MAPK_MEF2A_6 | 25 | 32 | PF00069 | 0.650 |
DOC_PP1_RVXF_1 | 33 | 40 | PF00149 | 0.650 |
DOC_PP1_RVXF_1 | 50 | 57 | PF00149 | 0.252 |
DOC_PP1_RVXF_1 | 92 | 98 | PF00149 | 0.806 |
DOC_PP4_FxxP_1 | 98 | 101 | PF00568 | 0.804 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.742 |
LIG_14-3-3_CanoR_1 | 21 | 25 | PF00244 | 0.650 |
LIG_14-3-3_CanoR_1 | 52 | 57 | PF00244 | 0.549 |
LIG_EVH1_2 | 110 | 114 | PF00568 | 0.792 |
LIG_FHA_1 | 61 | 67 | PF00498 | 0.549 |
LIG_LIR_Nem_3 | 23 | 27 | PF02991 | 0.650 |
LIG_LIR_Nem_3 | 55 | 59 | PF02991 | 0.549 |
LIG_NRBOX | 69 | 75 | PF00104 | 0.549 |
LIG_PDZ_Class_2 | 111 | 116 | PF00595 | 0.794 |
LIG_SH2_SRC | 27 | 30 | PF00017 | 0.650 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.650 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.339 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.678 |
LIG_SH3_3 | 27 | 33 | PF00018 | 0.650 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.798 |
LIG_TYR_ITIM | 70 | 75 | PF00017 | 0.549 |
LIG_WRC_WIRS_1 | 53 | 58 | PF05994 | 0.549 |
MOD_Cter_Amidation | 85 | 88 | PF01082 | 0.624 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.624 |
MOD_GlcNHglycan | 98 | 101 | PF01048 | 0.428 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.777 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.650 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.806 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.650 |
MOD_Plk_1 | 12 | 18 | PF00069 | 0.772 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.449 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.772 |
TRG_ENDOCYTIC_2 | 27 | 30 | PF00928 | 0.650 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.549 |